Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
作者信息
Lehoczky O, Bagaméri Andrea, Udvary J, Pulay T
机构信息
Gynecological Oncology Department, National Institute of Oncology, Budapest, XII, Ráth Gy.u. 7-9, Hungary, H-1122.
出版信息
J Obstet Gynaecol. 2002 May;22(3):312-3. doi: 10.1080/01443610220130661.
PMID:12521509
Abstract
摘要
相似文献
1
Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
J Obstet Gynaecol. 2002 May;22(3):312-3. doi: 10.1080/01443610220130661.
2
Emergency. Chemotherapy-induced hypersensitivity reaction.
Am J Nurs. 2000 Apr;100(4):53-4.
3
Single-dose dexamethasone paclitaxel premedication.
Gynecol Oncol. 1998 May;69(2):122-4. doi: 10.1006/gyno.1998.4993.
4
Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions.
Gynecol Oncol. 2006 Feb;100(2):437-8. doi: 10.1016/j.ygyno.2005.09.012. Epub 2005 Oct 14.
5
Eosinophilic ascites: taxol-induced hypersensitivity?
Cytopathology. 2004 Jun;15(3):171-2. doi: 10.1111/j.1365-2303.2004.00132.x.
6
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
Anticancer Drugs. 2000 Aug;11(7):565-8. doi: 10.1097/00001813-200008000-00007.
7
Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy.
Cancer Chemother Pharmacol. 2005 Jul;56(1):91-6. doi: 10.1007/s00280-004-0924-9. Epub 2005 Mar 25.
8
Taxol hypersensitivity: rapid retreatment is safe and cost effective.
Gynecol Oncol. 1998 Jan;68(1):25-8. doi: 10.1006/gyno.1997.4906.
9
[Taxol in the treatment of ovarian neoplasm].
Zhonghua Fu Chan Ke Za Zhi. 1999 Jul;34(7):439-41.
10
Paclitaxel-induced myocardial infarction in a case of carcinoma ovary.
J Assoc Physicians India. 2009 Apr;57:342-3.
Zotero 插件